Pacific Biosciences of California Inc

PACB

$30.25

+692.2% (1 year change)

Avg closing price

Price range

Market Cap

$5.86 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$3.35 - $53.69

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

0.0x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $5.86 Billion
Enterprise Value -
Dividend Yield $0.00 (0.0%)
1 Year Return +692.2%
52-Week High $53.69
52-Week Low $3.35
Beta 2.05
Outstanding Shares 198 Million
Avg 30 Day Volume 1.87 Million

Valuation

P/E Ratio 0.0
PEG -
Earnings per Share $0.00
Price to Sales Ratio -
Price to Book Ratio -
Revenue to Enterprise Value -
EBIT to Enterprise Value -
Total Debt to Enterprise Value -
Debt to Equity -

Profitability

Revenue -
Gross Profit -
EBIT -
Net Income -
Profit Margin -
Quarterly Earnings Growth (YoY) -
Return on Equity -
Return on Assets -
Return on Invested Capital -

News

Long Read Sequencing Market to Garner Overwhelming Hike in Revenues US$ 5,334.68 million by 2028 with Business Key Insights: Baseclear B.V., Bionano Genomics, Longas Technologies, Pacific Biosciences of California, Inc., Quantapore, Inc

Long Read Sequencing Market to Garner Overwhelming Hike in Revenues US$ 5,334.68 million by 2028 with Business Key Insights: Baseclear B.V., Bionano Genomics, Longas Technologies, Pacific Biosciences of California, Inc., Quantapore, Inc

The Long Read Sequencing Market was valued at US$ 1,101.15 million in 2020 and it is projected to reach US$ 5,334.68 million by 2028; it is expected to grow at a CAGR of 22.3% during 20212028. The ...

OpenPR OpenPR, 2 days ago
NGS-based RNA-seq market is estimated to reach US$ 7,984.90 Mn with a CAGR of 19.3% Till 2027 with Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Qaigen and others

NGS-based RNA-seq market is estimated to reach US$ 7,984.90 Mn with a CAGR of 19.3% Till 2027 with Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Qaigen and others

According to The Insight Partners market research study titled NGS- Based RNA- Seq Market to 2027 Global Analysis and Forecasts by Product & Services, Technology, Application and End User, []

iCrowdNewswire iCrowdNewswire, 23 days ago
Pacific Biosciences of California (PACB) Presents At BofA Securities 2021 Virtual Health Care Conference - Slideshow

Pacific Biosciences of California (PACB) Presents At BofA Securities 2021 Virtual Health Care Conference - Slideshow

No summary available.

Seeking Alpha Seeking Alpha, 26 days ago